-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UDQ6JWvWdaKTbZxigzCYXSEwgyjlXaKHN+pVm7d1zdL9brWwIw/exU/D1aJ9MNLk 8EwfcVezq6yYi4NBHgtY2g== 0001437749-10-003349.txt : 20101012 0001437749-10-003349.hdr.sgml : 20101011 20101012074959 ACCESSION NUMBER: 0001437749-10-003349 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20101012 DATE AS OF CHANGE: 20101012 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Zadini Giorgio C. CENTRAL INDEX KEY: 0001491350 FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: 2237 HILLTOP LANE CITY: CAMARILLO STATE: CA ZIP: 93012 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AtheroNova Inc. CENTRAL INDEX KEY: 0001377053 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201915083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-82426 FILM NUMBER: 101117444 BUSINESS ADDRESS: STREET 1: 2301 DUPONT DRIVE, SUITE 525 CITY: IRVINE STATE: CA ZIP: 92612 BUSINESS PHONE: (949) 525-5471 MAIL ADDRESS: STREET 1: 2301 DUPONT DRIVE, SUITE 525 CITY: IRVINE STATE: CA ZIP: 92612 FORMER COMPANY: FORMER CONFORMED NAME: AtheroNova, Inc. DATE OF NAME CHANGE: 20100519 FORMER COMPANY: FORMER CONFORMED NAME: Trist Holdings, Inc. DATE OF NAME CHANGE: 20080103 FORMER COMPANY: FORMER CONFORMED NAME: LandBank Group Inc DATE OF NAME CHANGE: 20061002 SC 13D/A 1 athero_13da2-100510.htm SCHEDULE 13D AMENDMENT NO. 2 athero_13da2-100510.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934
 
(Amendment No. 2)*
 
 
AtheroNova Inc.

(Name of Issuer)
 
 
Common Stock, par value $0.0001 per share

(Title of Class of Securities)
 
 
047438 205

(CUSIP Number)
 
 
Giorgio Zadini
c/o AtheroNova Inc.
2301 Dupont Drive, Suite 525
Irvine, California 92612
(949) 476-1100

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
 
 
September 17, 2010

(Date of Event which Requires Filing of this Statement)
 
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box ¨ .
 
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.
 
(Page 1 of 4)
 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
 
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 
 
CUSIP No.  047438 205
 
Page     2       of       
 
1
NAME OF REPORTING PERSON
SS. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Giorgio Zadini
 
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                                                                                                          (a) &# 160;¨
                                                                                                                                           60;                                                                                                     (b) þ
 
3
SEC USE ONLY
 
4
SOURCE OF FUNDS*
OO
 
5
CHECK BOX OF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)                                                   ¨
 
6
CITIZENSHIP OR PLACE OF ORGANIZATION
United States of America
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING
PERSON WITH
7
SOLE VOTING POWER
5,836,372
8
SHARED VOTING POWER
 
9
SOLE DISPOSITIVE POWER
5,836,372
 
10
SHARED DISPOSITIVE POWER
 
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,836,372
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*                                                                              ¨
 
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
25.7% (1)
14
TYPE OF REPORTING PERSON*
IN
 
(1)           Based on a total of 22,687,553 shares of the Company’s common stock outstanding as of September 7, 2010.
 
 
 

 
 
This Schedule 13D/A (“Schedule 13D/A”) amends the following sections of the Schedule 13D filed with the Securities and Exchange Commission on May 24, 2010 and amended on June 28, 2010 (“Schedule 13D”).
 
Item 3.  Source and Amount of Funds or Other Consideration.
 
Item 3 of Schedule 13D is supplemented and amended by the information below.
 
On September 9, 2010, the Reporting Person transferred 42,500 shares of Common Stock to certain parties as bona fide gifts.  From September 6, 2010 through September 17, 2010, the Reporting Person sold an aggregate of 199,250 shares of Common Stock to various purchasers.
 
Item 5.  Interest in Securities of the Issuer.
 
Item 5 of Schedule 13D is supplemented and amended by the information below.
 
Reference is made to the disclosure set forth under Item 3 this Schedule 13D/A, which disclosure is incorporated herein by reference.
 
As of September 17, 2010, the Reporting Person beneficially owned 5,836,372 shares of Common Stock (the “Shares”).  Since 22,687,553 shares of Common Stock were outstanding as of September 17, 2010, the Shares constitute approximately 25.7% of the shares of Common Stock issued and outstanding.
 
The Reporting Person has the sole power to vote or direct the vote of, and to dispose of or direct the disposition of, the Shares.
 
Transactions by the Reporting Person in Common Stock effected in the past 60 days are described in Item 3 above.
 
 
Page 3 of 4
 
 

 
 
SIGNATURE
After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this Schedule 13D/A is true, complete and correct.
 
 

Dated: October 11, 2010 
  /s/ Giorgio Zadini  
    Giorgio Zadini  
       
       
                                                                                       & #160;                                        
 
 
 

 
 
 
 
 
 
Page 4 of 4
-----END PRIVACY-ENHANCED MESSAGE-----